Study of Transcutaneous Electrical Nerve Stimulation TENS for Treating Chronic Low Back Pain in Adults Aged 18 to 60
Led by University of Hartford · Updated on 2024-12-04
34
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Chronic low back pain is a common and persistent health issue that often leads to increased pain sensitivity both at and away from the original pain site. This heightened pain response is linked to central sensitization, which can worsen with longer pain duration and intensity. The study explores how treatments that reduce this central excitability and boost pain inhibition might help, focusing on transcutaneous electrical nerve stimulation TENS as a non-drug, affordable, and simple option.
The trial uses a randomized crossover design where participants receive three different treatments in random order active TENS at a high intensity, placebo TENS with a brief stimulation then off, and a no-treatment control with the device turned off to keep assessors unaware. The active TENS aims to activate the bodys pain-blocking pathways and reduce central excitability, potentially improving the ability to exercise and function.
Participants undergo assessments measuring pain intensity at rest and during movement, pain sensitivity thresholds, and physical function tests such as sit-to-stand and repeated trunk flexion. These evaluations occur over a 3-week period, focusing on how TENS influences pain relief and physical ability. The study also monitors central pain modulation to understand TENS effects on pain processing.
CONDITIONS
Brief Title
Transcutaneous Electrical Nerve Stimulation (TENS) and Low Back Pain
Research Team
R
Richard E Liebano, PhD
R
Richard E Liebano, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Active TENS
Placebo TENS
No TENS
What it is
A wearable device delivering transcutaneous electrical nerve stimulation to the lower back while perceptible sensory‑level stimulation is titrated.
A sham TENS device mimicking sensory experience without delivering therapeutic electrical stimulation.
No TENS applied, serving as a baseline condition without device intervention.
Role in the trial
Investigational therapeutic condition undergoing direct evaluation.
Serves as placebo comparator to distinguish device effect from expectation.
Provides baseline condition without any intervention to compare against active stimulation.
Primary use
To evaluate if active electrical stimulation reduces chronic low‑back pain beyond placebo or no intervention.
To control for placebo effects and assess the specific impact of device stimulation.
To provide baseline measurement of pain and function without any device intervention.
How it is administered or performed
Participants receive TENS via skin electrodes with perceptible sensory‑level stimulation in randomized sequence.
Participants use a sham device designed to feel similar but without delivering therapeutic electrical currents.
Participants do not receive any device application during this condition.
Evidence status
Evidence for benefit is currently being collected through this clinical protocol; broader literature shows mixed and low‑certainty results for TENS in chronic low‑back pain.
Placebo controls allow determination of non‑specific effects; literature indicates similar outcomes between sham and active stimulation in many cases.
Baseline condition with no stimulation; literature shows that active TENS often does not outperform no intervention in longer‑term or functional outcomes.
Important risks
Minor skin irritation is possible; serious adverse events are rare according to previous studies.
Minor skin irritation possible; risk similar to active device.
No device‑related risks in the no‑intervention condition.
Important limitations
Evidence is limited by very low certainty, short‑term effects and inconsistent functional benefits.
Possible placebo response; hard to isolate true device effect without larger confirmatory trials.
Does not account for non‑device factors like expectation or natural fluctuation in pain.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 60Years
All Genders
Eligibility Criteria
You may qualify if you...
People who have experienced back pain for at least 3 months
Reported a minimal pain level of 3 on the 0-10 Pain Numerical Rating Scale
Age from 18 to 60 years
TENS naive or have not used TENS for 5 years
Both men and women may participate in the study
You will not qualify if you...
Serious spinal disorders such as fractures, tumors, or inflammatory arthritis disease
Nerve root disorders confirmed by neurological tests
Neurological diseases
Severe cardiorespiratory disease
Pregnancy
Skin infection, lesions, or change in sensation at the TENS application site
Cancer
Cardiac pacemaker
Allergy to electrodes
Use of opioids
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Approximately 9 weeks total (3 weeks per intervention)
Participants receive three different interventions in random order: active TENS, placebo TENS, and no treatment control. Each intervention lasts approximately 3 weeks.
Participants attend multiple visits during each 3-week intervention period for assessments.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Study of the PerQdisc Nucleus Replacement Device for Degenerative Disc Disease in Adults Aged 22 to 70
Master Protocol for Placebo-Controlled Trials of Multiple Treatments in Chronic Pain Conditions
Study of the SelfBack App to Support Self-Management of Chronic Low Back Pain
Through Alberta Chiropractors
Personalized Algorithm-Based Treatment for Chronic Low Back Pain Using Physical Therapy, Medication, Acupressure, and Cognitive Behavioral Therapy
Using the SOMA Smartphone App to Track Mood and Pain Changes in Adults with Acute and Chronic Pain Over Four Months
Study of Cryogenic Auriculotherapy Effects on Brain Imaging in Adults with Chronic Low Back Pain
Brain Imaging to Find Biomarkers Predicting Response to Spinal Cord Stimulation in Adults with Chronic Low Back Pain
Studying Brain, Psychological, and Epigenetic Factors to Improve Treatment for Adults with Chronic Low Back Pain
Evaluating Retinal Light Stimulation to Reduce Chronic Pain and Sensitivity in Adults with Fibromyalgia and Low Back Pain
Study of Clinician Satisfaction and Adoption of the VERABAND2 Activity Monitor in Adults with Chronic Low Back Pain
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effects of transcutaneous electrical nerve stimulation on pain, function, and descending inhibition in people with non-specific chronic low-back pain: a study protocol for a randomized crossover trial.
Richard E Liebano, Kathleen A Sluka, Joshua Roy...